Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02711761
Other study ID # 16-2015-105
Secondary ID
Status Completed
Phase N/A
First received March 14, 2016
Last updated July 8, 2016
Start date September 2015
Est. completion date May 2016

Study information

Verified date July 2016
Source Seoul National University Hospital
Contact n/a
Is FDA regulated No
Health authority Korea: Institutional Review Board
Study type Interventional

Clinical Trial Summary

prospective randomized double-blind controlled study


Description:

Total of 69 ASA (American Society of Anesthesiologist) physical status class I or II patients will be enrolled.

Randomly assigned to three group according to the depth of guide-wire prior to tissue dilation during central catheterization via right internal jugular vein. (Group 1: 15 cm / Group 2: 17.5 cm / Group 3: 20 cm)

Central catheterization will be performed by anesthesiologists who be blinded to this study protocol.

An investigator will monitor and record whether any arrhythmia will occur.

The incidence of occurrence of arrhythmia will be compared between three groups.


Recruitment information / eligibility

Status Completed
Enrollment 69
Est. completion date May 2016
Est. primary completion date March 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patients receiving general anesthesia requiring central venous catheterization via right internal jugular vein.

- ASA (American Society of Anesthesiologist) physical status class I or II

Exclusion Criteria:

- at the pre-anesthetic evaluation, history of any arrhythmia

- when monitoring before the induction of anesthesia in the operating room, newly arrhythmia is observed.

- abnormal electrolyte at the pre-anesthetic evaluation

- too difficult to access right internal jugular vein for central catheterization (too short neck, infection at the site of right internal jugular vein, ventriculoperitoneal shunt or chemo-port existence at the site of right internal jugular vein. too close site to operating field)

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Prevention


Related Conditions & MeSH terms

  • Patient Safety During Central Venous Catheterization

Intervention

Device:
central venous catheterization
15 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 15 cm. 17.5 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 17.5 cm. 20 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 20 cm.

Locations

Country Name City State
Korea, Republic of Seoul National University Boramae Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of arrhythmia during central venous catheterization Yes
See also
  Status Clinical Trial Phase
Completed NCT03116724 - Direct Measurement of Ideal Depth of Central Line N/A